Insider track record
OtherAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Yocca Frank. Officer active across 1 company, notably BioXcel Therapeutics, Inc.. In total, 16 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €1.4m. History available since 20 January 2023. The latest transaction was filed on 20 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations16 total
17,500 sharesCommon StockSEC:0001104659-26-065841:0
6,845 shares@ US$1.0850.021% mcap0.5% of flowCommon StockSEC:0001104659-26-065841:1
33 sharesCommon StockSEC:0001104659-25-090514:0
35 sharesCommon StockSEC:0001104659-25-090514:1
4,375 sharesCommon StockSEC:0001104659-25-069702:0
31 sharesCommon StockSEC:0001104659-25-024532:0
521 sharesCommon StockSEC:0001104659-24-129457:0
21,250 sharesCommon StockSEC:0001104659-24-106062:0
521 sharesCommon StockSEC:0001104659-24-100752:0
521 sharesCommon StockSEC:0001104659-24-073004:0
521 sharesCommon StockSEC:0001104659-24-044857:0
521 sharesCommon StockSEC:0001104659-23-126926:0
521 sharesCommon StockSEC:0001104659-23-101641:0
521 sharesCommon StockSEC:0001104659-23-072398:0
2,084 sharesCommon StockSEC:0001104659-23-033406:0
50,000 shares@ US$30.0099.5% of flowCommon StockSEC:0001104659-23-006298:0